GURUFOCUS.COM » STOCK LIST » USA » NYSE » Becton, Dickinson and Co (NYSE:BDX) » Definitions » ROE %
Switch to:

Becton, Dickinson and Co ROE %

: 5.41% (As of Jun. 2022)
View and export this data going back to 1963. Start your Free Trial

ROE % is calculated as Net Income attributable to Common Stockholders (Net Income minus dividends to participating security holders) divided by its average Total Stockholders Equity over a certain period of time. Becton, Dickinson and Co's annualized net income attributable to common stockholders for the quarter that ended in Jun. 2022 was $1,352 Mil. Becton, Dickinson and Co's average Total Stockholders Equity over the quarter that ended in Jun. 2022 was $25,010 Mil. Therefore, Becton, Dickinson and Co's annualized ROE % for the quarter that ended in Jun. 2022 was 5.41%.

The historical rank and industry rank for Becton, Dickinson and Co's ROE % or its related term are showing as below:

BDX' s ROE % Range Over the Past 10 Years
Min: 0.94   Med: 10.7   Max: 28.18
Current: 6.83

During the past 13 years, Becton, Dickinson and Co's highest ROE % was 28.18%. The lowest was 0.94%. And the median was 10.70%.

BDX's ROE % is ranked better than
58.48% of 802 companies
in the Medical Devices & Instruments industry
Industry Median: 0.60 vs BDX: 6.83

Becton, Dickinson and Co ROE % Historical Data

The historical data trend for Becton, Dickinson and Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.01 0.94 5.14 3.42 8.44

Becton, Dickinson and Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.20 4.05 10.95 7.08 5.41

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Becton, Dickinson and Co ROE % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's ROE % distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's ROE % falls into.



Becton, Dickinson and Co ROE % Calculation

Becton, Dickinson and Co's annualized ROE % for the fiscal year that ended in Sep. 2021 is calculated as

ROE %=Net Income attributable to Common Stockholders (A: Sep. 2021 )/( (Total Stockholders Equity (A: Sep. 2020 )+Total Stockholders Equity (A: Sep. 2021 ))/ count )
=2002/( (23765+23677)/ 2 )
=2002/23721
=8.44 %

Becton, Dickinson and Co's annualized ROE % for the quarter that ended in Jun. 2022 is calculated as

ROE %=Net Income attributable to Common Stockholders (Q: Jun. 2022 )/( (Total Stockholders Equity (Q: Mar. 2022 )+Total Stockholders Equity (Q: Jun. 2022 ))/ count )
=1352/( (24526+25494)/ 2 )
=1352/25010
=5.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income attributable to common stockholders of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income attributable to common stockholders data used here is four times the quarterly (Jun. 2022) net income attributable to common stockholders data. ROE % is displayed in the 30-year financial page.


Becton, Dickinson and Co  (NYSE:BDX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=1440/25010
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1440 / 18564)*(18564 / 53992.5)*(53992.5 / 25010)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.76 %*0.3438*2.1588
=ROA %*Equity Multiplier
=2.67 %*2.1588
=5.76 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=1440/25010
=(Net Income /Pre-Tax Income) * (Pre-Tax Income/Operating Income) * (Operating Income/Revenue) * (Revenue/Total Assets) * (Total Assets/Total Stockholders Equity)
= (1440 / 1684) * (1684 / 2368) * (2368 / 18564) * (18564 / 53992.5) * (53992.5 / 25010)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8551 * 0.7111 * 12.76 % * 0.3438 * 2.1588
=5.76 %

Note: The net income attributable to common stockholders data used here is four times the quarterly (Jun. 2022) net income attributable to common stockholders data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.


Be Aware

Net income attributable to common stockholders is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Becton, Dickinson and Co ROE % Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co Business Description

Becton, Dickinson and Co logo
Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Executives
Hickey David officer: EVP & President, Life Sciences BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Neal Shana Carol officer: Chief People Officer 9120 LOCKWOOD BOULEVARD MECHANICSVILLE VA 23116
Ezell Antoine C officer: EVP, President, NA & CMO BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Spoerel Thomas J officer: VP Controller & Chief Acct Off BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Brown William M director HARRIS CORPORATION 1025 W NASA BOULEVARD MELBOURNE FL 32919
Larson Betty D officer: EVP HR & CHRO C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974
Khichi Samrat S. officer: EVP and General Counsel C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Conroy Alexandre officer: EVP of Integrated Supply Chain BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Campion Simon D officer: EVP and Segment President BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Scott Bertram L director C/O BECTON DICKERSON & CO 1 BECTON DR FRANKLIN LAKES NJ 07417
Jones Christopher Ian Montague director 110, BANBURY ROAD OXFORD X0 OX2 6JU
Pomeroy Claire director BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417
Fraser Claire director C/O BECTON, DICKINSON AND COMPANY FRANKLIN LAKES NJ 07465
Melcher David F director 1650 TYSONS BOULEVARD SUITE 1700 MCLEAN VA 22102
Byington Carrie L director BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417

Becton, Dickinson and Co Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)